New care model aims to ease suffering for leukemia patients
NCT ID NCT02975869
Summary
This study tested whether adding a palliative care team to standard cancer treatment could improve the experience for patients with acute myeloid leukemia (AML). Palliative care specialists focus on managing symptoms and providing emotional support. The trial involved 160 hospitalized patients with high-risk AML to see if this combined approach led to better quality of life, less distress, and improved end-of-life care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27710, United States
-
Massachusetts general Hospital
Boston, Massachusetts, 02114, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 16802, United States
Conditions
Explore the condition pages connected to this study.